Right now the price per share is 1,48$, Tcr2 Therapeutics Inc is a company created in United States dedicated to Biotechnology: Pharmaceutical Preparations with its highest number of sales in North America. Its Executives are Alfonso Quintßs-Cardama (Chief Medical Officer), Garry E. Menzel (President, Chief Executive Officer & Director), Mayur Ian Somaiya (Chief Financial Officer), Peter Olagunju (Chief Technical Officer), Robert Hofmeister (Chief Scientific Officer) and its address is 100 BINNEY STREET SUITE 710, CAMBRIDGE, Massachusetts, 2142, United States.
The closing price of the stock yesterday was desconocido$.
The current range on the same day is from 1,48$ - 1,63$, with a percentage difference of 1,56$ quite wide that helps to be able to do day trading.
Their latest annual data shows an income of desconocido.
The opening price that appears as last recorded is desconocido.
If we think of formulas to know when to buy or sell a stock, a value that appears in them always comes to mind, which is the range between the lowest and the highest price that the stock has obtained, for example, here it has been between 0,00$ and 0,00$.
The EPS, or net profit divided by the number of shares in progress, tells us with a high value that we must enter and with a low value that we must leave, it is a result of how the company has done in the last year.
Buscar
